- Home
- / Grand Pharmaceutical Group
Grand Pharmaceutical Group
Stock Price
$4.7
2024-10-29
Market Capitalization
$16 B
2024-10-29
Revenue
$12.3 B
FY, 2025
Grand Pharmaceutical Group Summary
Company Summary
- Overview
- Grand Pharmaceutical Group (遠大醫藥集團有限公司) is a company engaged in the research, development, and manufacturing of pharmaceutical products. It offers medical devices, bio-feed additives, Metronidazole tablets, oncology products, etc.
- Type
- Public
- Status
- Active
- Founded
- 1995
- Cybersecurity rating
Table of Contents
Grand Pharmaceutical Group Financials
Summary Financials
- Revenue (FY, 2025)
- $12.3B
- Gross profit (FY, 2025)
- $8.1B
- Net income (FY, 2025)
- $1.2B
- Cash (FY, 2025)
- $1.1B
- EBIT (FY, 2025)
- $1.9B
- Enterprise value
- $20.6B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026